Iclusig – Talk Bio

Actionable Insights Powered by AI

Takeda’s $5.2B Ariad Deal Yields Label Expansion for Iclusig in Rare Leukemia

1 year ago talkbio0Tagged 5.2B, Ariad, expansion, Iclusig, Infrequent, Labels (device), leukemia, Takeda

Takeda, Ariad, $5.2B deal, Iclusig, Label expansion, Rare form of leukemia